Overview

Safety, Pharmacokinetics and Efficacy of Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Premenopausal Women With Uterine Fibroids Who Have Completed ZPV-200

Status:
Completed

Trial end date:
2014-04-01

Target enrollment:

Participant gender:

Summary

To further determine the safety and efficacy of Proellex in premenopausal women with uterine fibroids who have previously completed study ZPV-200.

Phase:

Phase 2

Details

Lead Sponsor:

Repros Therapeutics Inc.